Correlation Between Ardelyx and Onconova Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Onconova Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Onconova Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Onconova Therapeutics, you can compare the effects of market volatilities on Ardelyx and Onconova Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Onconova Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Onconova Therapeutics.
Diversification Opportunities for Ardelyx and Onconova Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Ardelyx and Onconova is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Onconova Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Onconova Therapeutics and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Onconova Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Onconova Therapeutics has no effect on the direction of Ardelyx i.e., Ardelyx and Onconova Therapeutics go up and down completely randomly.
Pair Corralation between Ardelyx and Onconova Therapeutics
If you would invest 102.00 in Onconova Therapeutics on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Onconova Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 0.53% |
| Values | Daily Returns |
Ardelyx vs. Onconova Therapeutics
Performance |
| Timeline |
| Ardelyx |
| Onconova Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Ardelyx and Onconova Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ardelyx and Onconova Therapeutics
The main advantage of trading using opposite Ardelyx and Onconova Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Onconova Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Onconova Therapeutics will offset losses from the drop in Onconova Therapeutics' long position.| Ardelyx vs. BioLineRx | Ardelyx vs. Lexicon Pharmaceuticals | Ardelyx vs. Seres Therapeutics | Ardelyx vs. Immunitybio |
| Onconova Therapeutics vs. Jaguar Animal Health | Onconova Therapeutics vs. Ibio Inc | Onconova Therapeutics vs. GeoVax Labs | Onconova Therapeutics vs. Ocugen Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |